Daquan Wang

发表

Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study

Xiaodong Zhang, J. Dai, Zongmei Zhou, 2020, Cancer management and research.

Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017).

Junye Wang, H. Long, Qi-wen Li, 2021, Lung cancer.

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy

Ping Wang, Lujun Zhao, Zhiyong Yuan, 2018, Cancer management and research.

Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes

Chaojie Zheng, Yun Zhou, Xu Zhang, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapy.

Haoqiang He, Qi-wen Li, Daquan Wang, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy

Lei Wu, Qingping Wu, Jumei Zhang, 2022, Frontiers in Cellular and Infection Microbiology.

Developing and Validating an Integrated Gross Tumor Volume (GTV)-TNM Strati cation System for Supplementing Unresectable Locally Advanced Non- small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy

Daquan Wang, B. Qiu, N. Chen, 2020 .

The effect of nodal downstage on long-term outcome for patients of non-small-cell lung cancer with IIIA-N2 stage

Ping Wang, Lujun Zhao, Q. Pang, 2016 .

Concurrent chemoradiotherapy with or without nimotuzumab in locally advanced squamous cell lung cancer: a phase 2 randomized trial.

Yong-hong Hu, Yi-mei Liu, Jun Zhang, 2021, International journal of radiation oncology, biology, physics.

Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: a phase I trial (GASTO-1021).

Jibin Li, Qi-wen Li, Daquan Wang, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy

N. Bi, Tao Zhang, Daquan Wang, 2022, Frontiers in Immunology.

Sparing lung tissue with virtual block method in VMAT planning for locally advanced non-small cell lung cancer

J. Dai, K. Men, N. Bi, 2022, Nuclear Science and Techniques.

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies

Fanjun Meng, Daquan Wang, Shao-Han Yin, 2022, Frontiers in Oncology.

Organ at risks sparing with simultaneous integrated boost volumetric modulated arc therapy for locally advanced non-small lung cancer: an automated treatment planning study

Xiaodong Zhang, J. Dai, Zongmei Zhou, 2020 .

Complete remission after hypofractionated radiotherapy for a patient with inoperable adenoid cystic carcinoma of bronchus

Luhua Wang, N. Bi, Daquan Wang, 2018, Medicine.

A Validation Study on the Lung Immune Prognostic Index for Prognostic Value in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Jun Liang, Jianyang Wang, Zongmei Zhou, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Zhengfei Zhu, Z. J. Cheng, Jibin Li, 2020, Radiation oncology.

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study

Jun Liang, Zongmei Zhou, Q. Feng, 2019, Radiation Oncology.

Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis

Yuankai Shi, Daquan Wang, Q. Zhong, 2020, Cancer Immunology, Immunotherapy.

Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045)

Wenfeng Ye, Daquan Wang, J. Guo, 2023, Frontiers in Oncology.

IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy

Yibo Gao, N. Bi, Tao Zhang, 2023, Journal of oncology.

Moderately Hypofractionated Once-daily Compared with Twice-daily Thoracic Radiotherapy Concurrently with Etoposide and Cisplatin in Limited-stage Small-cell Lung Cancer: a Multi-center, Phase II, Randomized Trial.

C. Xie, Zhengfei Zhu, Q. Pang, 2021, International journal of radiation oncology, biology, physics.

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases

Haoqiang He, Pengxing Zhang, Daquan Wang, 2023, Clinical and translational radiation oncology.

Diagnostic Signatures for Lung Cancer by Gut Microbiome and Urine Metabolomics Profiling.

Lei Wu, Juan Wang, Qingping Wu, 2021, International Journal of Radiation Oncology, Biology, Physics.

Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model.

Shiyu Huang, Jibin Li, N. Bi, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Jia Fu, Chaojie Zheng, Xu Zhang, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients

Daquan Wang, J. Guo, B. Qiu, 2022, Frontiers in Oncology.

Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial

Q. Pang, Wencheng Zhang, Daquan Wang, 2018, OncoTargets and therapy.

Jun Liang, Zongmei Zhou, Q. Feng, 2019, Radiation oncology.

Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials

H. Yao, Yunfang Yu, Daquan Wang, 2023, Breast.

Greater negative lymph node count predicts favorable survival of patients with breast cancer in the setting of neoadjuvant chemotherapy and mastectomy.

Ping Wang, Xin Wang, Daquan Wang, 2019, Future oncology.

Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients.

Chaojie Zheng, Xu Zhang, Daquan Wang, 2023, European journal of nuclear medicine and molecular imaging.

Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data

Y. Wang, H. Yao, Yunfang Yu, 2023, Translational oncology.

Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)

Mengzhong Liu, Yong-hong Hu, M. Xi, 2023, Cancer medicine.